CellCentric Ltd. and ZoBio Enter into Partnership to Develop Lead Compounds Against Epigenetic Drug Targets
6/20/2012 10:06:59 AM
More...
|
CellCentric Ltd. Licenses Novel Epigenetic Discovery Program to Takeda Pharmaceutical Co. Ltd. (TKDG.DE) (JOBS); Deal Could be Worth Excess of $200 Million
2/23/2010 10:11:29 AM
More...
|
CellCentric Ltd. Secures 25th Epigenetics Academic Agreement
4/21/2009 1:25:33 PM
More...
|
CellCentric Ltd. Expands its Leadership Team
2/4/2009 2:08:09 PM
More...
|
CellCentric Ltd. and Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Collaborate on Epigenetic Programme
1/6/2009 1:04:31 PM
More...
|
Cenix BioScience GmbH and CellCentric Ltd. Second RNAi-Based Target Validation Project
7/1/2008 2:10:33 PM
More...
|
Following Success of Pilot, Cenix BioScience GmbH Takes on Second RNAi-Based Target Validation Project for CellCentric Ltd.
7/1/2008 10:08:06 AM
More...
|
Cenix BioScience GmbH and CellCentric Ltd. Sign Framework Research Agreement for RNAi-Based Target Validation
3/20/2008 8:44:55 AM
More...
|
CellCentric Ltd. and Cancer Research Technology Collaborate on Epigenetic Discoveries
11/14/2007 12:24:47 PM
More...
|
Argenta Discovery Inc. Announces Contract Drug Discovery Collaboration with CellCentric Ltd.
10/3/2007 11:08:59 AM
More...
|
|